ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

LYRA Lyra Therapeutics Inc

0.3876
0.02 (5.44%)
May 17 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 407k-4.42M11k410k458k544k146k532k
Operating Income -14.24M-19.61M-15.16M-17.31M-14.91M-16.83M-18.07M-23.52M
Pre Tax Income -14.2M-19.55M-14.22M-16.24M-15.61M-15.64M-15.14M-22.44M
Net Income -14.2M-19.55M-14.24M-16.26M-15.62M-15.65M-15.16M-22.45M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -14.24M-19.61M-15.16M-17.31M-14.91M-16.83M-18.07M-23.52M
EBITDA -13.92M-19.36M-13.62M-17.03M-14.93M-16.9M-16.39M-23.39M
Year End December 30 2023 201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.24M00285k1.36M1.56M
Operating Income -7.26M-16.52M-22.21M-43.62M-56.31M-67.12M
Pre Tax Income -6.03M-16.31M-22.13M-43.51M-55.27M-62.62M
Net Income -6.03M-16.31M-22.13M-43.51M-55.28M-62.68M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -35.465-70.896-1.711-3.345-1.737-1.192
EBIT -7.25M-16.52M-22.21M-43.62M-56.31M-67.12M
EBITDA -7.18M-16.49M-22.11M-42.61M-53.92M-65.25M